Asabys Partners, a Barcelona, Spain-based life sciences focused venture capital firm, closed its second fund, Sabadell Asabys Health Innovation Investments II (SAHII II), with total commitments of €180m.
LPs included new US and international investors in addition to investors from its previous fund, SAHII I, which closed with €117m in commitments.
Read more on VCWire.tech, our new website dedicated to the tech venture capital industry.
FinSMEs
26/09/2024